Navigation Links
Dr. Christopher Olivia Appointed to Foundation Radiology Group Board of Directors
Date:7/27/2009

PITTSBURGH, July 27 /PRNewswire/ -- Foundation Radiology Group (FRG), a premier provider of diagnostic imaging professional services headquartered in downtown Pittsburgh, is pleased to announce the appointment of Dr. Christopher Olivia, M.D., M.B.A., to its Board of Directors.

Dr. Olivia, current President and CEO of West Penn Allegheny Health System (WPAHS), brings an extensive resume of leadership skills to FRG's Board.

"The addition of Dr. Olivia to our Board illustrates the level of excellence that we are striving for at Foundation Radiology Group," said FRG Chairman and CEO, Dr. Brandon Chan. "Dr. Olivia's experience, insights, and leadership as both a doctor and businessman will be invaluable to our organization."

West Penn Allegheny Health System, a six-hospital academic system with two major teaching facilities, is the second largest private employer in Western Pennsylvania. During his tenure at WPAHS, Dr. Olivia has reorganized the System's leadership structure and devised operational performance improvement assessment and implementation plans, negotiated a significantly improved contract with the region's dominant payor, secured gains in public funding, reorganized the System's Graduate Medical Education programs and established quality and financial goals for the System.

Prior to his current role at WPAHS, Dr. Olivia served as President and CEO for The Cooper Health System (CHS) in Camden, NJ, where he led the organization, which was previously on the verge of bankruptcy, to significant financial growth. Under Dr. Olivia's stewardship, CHS rose to the No. 1 ranking in market shares among hospitals in the southern areas of New Jersey, amassed $25 million in federal funding and had the most financially successful years in its 120-year history. The Cooper Health System is New Jersey's only academic medical center and one of three principal teaching hospitals of t
'/>"/>

SOURCE Foundation Radiology Group
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. St. Christophers Foundation For Children Ronald McDonald(R) Care Mobile Making Tri-State Visits to Provide Dental Care to Children at No Cost
2. Christopher and Dana Reeve Foundation Lauds U.S. House of Representatives Passage of the Christopher and Dana Reeve Paralysis Act
3. COLORBLENDS to Donate Portion of Sales of Spring Forward Daffodil Blend to the Christopher and Dana Reeve Foundation
4. Christopher Reeve Honored as Heroes Hero By CNN
5. Hahnemann University Hospital and St. Christophers Hospital for Children Receive Prestigious Tenet Circle of Excellence Award
6. Hahnemann University Hospital and St. Christophers Hospital for Children Extend Current Agreement With Independence Blue Cross
7. XTENT Appoints Christopher M. Smith and Arthur T. Taylor to Board of Directors
8. Matthew Reeve to Host The Christopher and Dana Reeve Foundations Annual Hamptons Summer Soiree
9. Chicago Artist Tadeusz Seidel Supports Christopher & Dana Reeve Foundation Chicago Chapter Benefit
10. Christopher & Dana Reeve Foundation Launches First-Ever National Advertising Campaign
11. AmericInn Hotels Partners With Nationally Recognized Sleep Expert Dr. Christopher Drake, Announces Launch of Sleep Better America Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 3ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 2For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain 3UC Davis study highlights work life issues of female surgeons 52395 1UC Davis study highlights work life issues of female surgeons 52395 2Fecal incontinence and quality of life 52393 1Early rice harvests ease annual famine in Bangladesh 9316 1Early rice harvests ease annual famine in Bangladesh 9316 2